SF3B1 and B-cell chronic lymphocytic leukemia: Mutated SF3B1 in CLL has been associated with dysregulated DNA damage response, telomere dysfunction, increased Notch signaling mediated through a splice variant of DVL2, and activation of NF-κB signaling facilitated by alternative splicing of MAP3K7 [3, 16].